Couverture de Power to the Patients

Power to the Patients

Power to the Patients

De : Brandon Li
Écouter gratuitement

À propos de ce contenu audio

 Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com315762 Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Beyond Dopamine: Why Traditional Schizophrenia Treatments Miss 50% of Patient Needs

      Beyond Dopamine: Why Traditional Schizophrenia Treatments Miss 50% of Patient Needs
      Feb 4 2026
      In this episode of Power to the Patients, Brandon Li sits down with Dr. Laxminarayan Bhat, Founder and CEO of Reviva Pharmaceuticals, to explore groundbreaking developments in schizophrenia treatment. Dr. Bhat shares insights on his company's innovative drug that shows promising results with fewer side effects and better patient adherence than existing treatments. Discover how their unique approach to targeting serotonin-dopamine signaling, combined with reduced off-target effects, could transform the lives of millions living with schizophrenia. Learn about the challenges and triumphs of developing psychiatric medications, the role of biomarkers in treatment, and the future of precision psychiatry.
      Afficher plus Afficher moins
      32 min
    • The 20-Year Industry Secret: Redefining Neurodegenerative Treatment

      The 20-Year Industry Secret: Redefining Neurodegenerative Treatment
      Jan 9 2026
      In this episode of Power to the Patients, Brandon Li sits down with Dr. Gabriel Vargas, Chief Medical Officer at CuraSen Therapeutics, to explore how targeting the adrenergic system could offer both symptomatic relief and disease-modifying potential for Alzheimer's, Parkinson's, and depression. From his two decades developing breakthrough therapies in neurology and psychiatry, including the migraine treatment Erenumab, Dr. Vargas breaks down translational medicine, challenges the amyloid hypothesis, and reveals why shorter clinical trials may be missing the bigger picture.
      Afficher plus Afficher moins
      53 min
    • One Mechanism, Three Conditions: A New Direction in Neurological Treatment

      One Mechanism, Three Conditions: A New Direction in Neurological Treatment
      Dec 3 2025
      What if inflammation was the key to unlocking treatments for Alzheimer's, Parkinson's, and Long COVID? In this episode of Power to the Patients, Brandon Li sits down with Cuong Do, CEO of BioVie, to explore the fascinating intersection of these seemingly unrelated conditions. From diving into medical research at the age of 14 to leading groundbreaking clinical trials, Cuong shares invaluable insights on biotech innovation, trial design, and navigating today's challenging funding landscape. Tune in to discover how a single molecule's unique ability to cross the blood-brain barrier could potentially transform treatment for millions of patients.
      Afficher plus Afficher moins
      35 min
    Aucun commentaire pour le moment